Devices designed for neuromodulation applications use a combination of metallic, thermoplastic, and silicone materials. Neurostimulation leads ( Figure  1 ) demonstrate the need for combining materials, a metallic electrode is encased in an insulative silicone and/or thermoplastic sheath to deliver a controlled electric signal to a targeted area. Advancements in cochlear implants, the most common neurobionic prosthetic device currently on the market, have deemed silicone coated titanium casings to be more water tight and stable than ceramic alternatives. As neuromodulation and neurobionic prosthetic devices are used in new treatment methods, it will be critical to have smaller and more sensitive electrode arrays with increased flexibility. These needs are driving developers to consider wider ranges of metals and elastomeric materials. The Elkem team has assessed the adhesion strength and ideal surface preparation of these materials (Table 1) with Silbione® Biomedical AHD1 M200, a monocomponent, tin free adhesive that cures in ambient conditions. This adhesive was selected based on the processing advantages it offers in conjunction with a formulation that offers regulatory peace of mind (Table 2) .
INTRODUCTION
The neuroengineering field is defined by the coupling of engineering and neuroscience; bringing together two different, but complimentary entities. Similarly, to create a successful neuroengineering device, it is necessary to couple the strengths of various, and sometimes distinctly different materials. Already, neurological devices have been successfully used to treat hearing loss, chronic pain, and epilepsy among other disorders. As these devices advance, soon Parkinson's disease, dementia, Alzheimer's, obesity, and sleep apnea may be added to that list. The realm of possibility for applying neuroengineering to medical devices is vast, but options for pairing the materials to make these advancements is more limited.
Three hurdles that exist in selecting materials are creating a bond between substrates, developing a simple and feasible manufacturing process, and selecting materials that meet not only current regulatory guidelines, but follow regulatory trends for the future. New adhesive technologies are an option to help overcome these hurdles by widening the range of material options to pursue new therapies. Elkem Silicones seeks to create novel materials that can push the boundaries of existing devices and create new possibilities for the future. This paper will explore the performance of a novel adhesive designed to meet evolving regulatory requirements, optimize production processes, and overcome the barriers of material selection by bonding with a variety of substrates for use in the field of neuroengineering.
Versatile Innovative Adhesive for Medical Implants ADH1 M200 a biocompatible designed specifically for situations where a high strength elastic bond to silicone, thermoplastic and metal substrates is required. This adhesive uses a non-tin based catalyst to promote a polycondensation reaction at ambient temperature (23°C) and humidity. The mechanism of cure is demonstrated in Figure 2 .
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SAMPLE PREPARATION & ANALYSIS
Adhesion of ADH1 M200 to each of the substrates (Table 1) was determined by testing the failure mode of prepared samples. Each substrate was used to prepare four samples that differed in surface preparation-no preparation, application of Silbione M&P Primer, OpenAir™ Plasma treatment, and a combination of primer application and plasma treatment.
Samples of the substrates adhered with Silbione Biomedical AHD1 M200 were prepared as outlined in ASTM D1005 and cured at ambient temperature (23°C) and humidity (50%) for 7 days before testing ( Figure 3 ). Samples were then evaluated with a 180°peel test according to ASTM D903 ( Figure 4 ). Peeled samples were observed an determined if the mode of failure was cohesive, the adhesive or substrate breaks before separation from the substrate ( Figure 5 ), or adhesive, the adhesive separates from the substrate without breaking ( Figure 6 ). The goal of this experiment to determine which combination of surface preparations will lead to cohesive failure. 
RESULTS
Each of the substrates were successfully bonded and a surface preparation method to yield cohesive failure was determined (Table 3) . No surface preparation was required to yield cohesive failure with Carbothane PC 3572D, Pellethane 2363-75D, and Silbione HCRA 4150 substrates. Tecothane Soft AR62A, Tecoflex RG-80A, and Pellethane 2363-90A required application of Silbione M&P Primer to the surface of the substrate for a cohesive failure mode. Tecothane 1075-75D, and each of the metallic substrates demonstrated cohesive failure with either OpenAir plasma treatment, or application of the primer. When both plasma and primer surface treatments were applied, all samples failed cohesively. 
CONCLUSION
The three hurdles to advancements in the development of new neurological medical devices; bonding a wide range of substrates, optimized manufacturing processes, and following regulatory guidelines and trends are significantly lowered with the introduction of Silbione Biomedical ADH1 M200. In the peel tests conducted, each substrate was prepared in a manner that lead to cohesive failure; showing the bond between adhesive and substrate is stronger than the adhesive itself. Results were achieved by curing the adhesive at room temperature and ambient humidity compared to other technologies which require costly ovens an humidity chambers to cure.
Manufactures now have an option for a fast and relatively simple processing set up that requires less energy than using silicone adhesives currently on the market. The experiment results and product properties have demonstrated substituting a new catalyst for commonly used tin catalysts causes no negative impact. In fact, as tin comes under increased scrutiny from regulatory institutions, a tin free formulation is desirable. With the hurdles to development lowered, increased innovation in the neuroengineering field is imminent. The time where neurological devices can be used to treat Alzheimer's, obesity, sleep apnea, and so many more diseases is closer than ever. 
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